Zoe Zhang, PhD
Manager, Biopharma Applications, SCIEX
Comprehensive Analysis of Next-Generation Biologics
New methods, techniques and efficient data analysis software in liquid chromatography-tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability.
Advanced Technology To Accelerate Development of Next-Generation Biotherapeutics
Biopharmaceutical companies are transitioning from the development of standard monoclonal antibody therapies to more intricate antibody structures and new genetic medicines. Not only are these molecules more complex, but scientists are also under tremendous pressure to understand molecular liabilities sooner and close the developability gap in a much shorter time frame.
Ensuring Safety and Efficacy of Biotherapeutics Through In-Depth LC-MS Sequence Variant Analysis
In this webinar, we will show you how to find and confirm sequence variants more easily using the right mass spectrometry tools.